FRCPath (Haematology), CCT Haematology, MRCP, MD, DCH, MB.BS
Consultant haematologist with 17 years NHS experience in blood disorders and cancer-related blood conditions
Experience
—
Languages
Bengali, English, Hindi, Marathi, Odhiya, Urdu
Location
Al Barsha, Dubai
Sees
adults
Dr Satyajit Sahu is a Consultant Haematologist with deep expertise across all blood and bone-marrow disorders. He graduated from Grant Medical College in Bombay in 1989 and qualified in Paediatric Medicine from Seth G.S Medical College in Mumbai in 1992. After training in Clinical Haematology at leading Indian hospitals including Tata Memorial Hospital and Cancer Institute, he moved to the UK in 1996 and completed his adult physician qualification and specialist haematology training at prestigious centres including Royal Marsden Hospital and King's College Hospital, London. From 2006 to 2023, he served as a Consultant Haematologist in the NHS, latterly at Queen Elizabeth Hospital and Lewisham & Greenwich NHS Trust, delivering 17 years of clinical care across both NHS and private sectors.
Dr Sahu diagnoses and manages the full spectrum of blood and bone-marrow conditions, from anaemias (iron deficiency, sickle cell, thalassaemia) to serious cancers (leukaemia, lymphoma, myeloma) and clotting disorders. He has particular expertise in laboratory blood analysis, bone-marrow reporting, and transfusion medicine. His clinical interests centre on haemato-oncology, with a special focus on lymphoma and myeloma management. He has led clinical trials, held multiple NHS leadership roles including Clinical Director of Pathology and Transfusion Lead, and collaborated with pharmaceutical companies on research and innovation.
Dr Sahu is well suited to patients with complex or rare blood disorders, those requiring specialist cancer-haematology input, or anyone needing expert diagnosis through blood and bone-marrow testing. His background in both paediatric and adult medicine, combined with extensive laboratory expertise, makes him a comprehensive resource for blood-related health concerns.
Special interests: lymphoma management, myeloma management, iron metabolism disorders, clinical trials and research.
Extracted from the doctor's hospital profile — patient-friendly terms
MB.BS
Grant Medical College & J.J. Group of Hospitals, India · 1989
MD (Paediatric Medicine) and DCH
Seth G.S Medical College & King Edward Memorial Hospital, India · 1992
MRCP (Member, Royal College of Physicians)
Royal College of Physicians, UK
CCT Haematology (Certificate of Completion of Training)
Royal Marsden Hospital and St George's Group of Hospitals, UK
FRCPath (Fellow, Royal College of Pathologists – Haematology)
Royal College of Pathologists, UK
Consultant Haematologist
Queen Elizabeth Hospital & Lewisham & Greenwich NHS Trust, Woolwich, London, UK · 2014-2023
Consultant Haematologist
NHS Services, UK · 2006 onwards
Trainee in Clinical Haematology & Laboratory Medicine
Royal Marsden Hospital, King's College Hospital, St George's Hospitals, UK
Trainee in Clinical Haematology & Laboratory Medicine
KEM Hospital Mumbai, CMC & Hospital Vellore, Tata Memorial Hospital and Cancer Institute, India · 1992-1996
Consultations are available in Bengali, English, Hindi, Marathi, Odhiya, Urdu.
Mediclinic — Mediclinic Parkview Hospital Physician consultant clinical haematology In department Haematology, Al Barsha, Dubai.
This doctor primarily sees adults.
Commonly treated: Aplastic Anemia, Immune Thrombocytopenia (Itp), Infections in Immunocompromised Patients, Iron Deficiency Anemia, Leukemia, Lymphoma, Myeloma, Sickle Cell Disease.
Profile compiled from Mediclinic's public website (see original profile via the booking link). Data is informational, not medical advice.
Mediclinic Parkview Hospital: 3.6★ · 5,034 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Satyajit Sahu? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.